Literature DB >> 27497372

Aiding the diagnosis of AD/HD in childhood: Using actigraphy and a continuous performance test to objectively quantify symptoms.

Hannah Gilbert1, Ling Qin2, Dandan Li3, Xuehua Zhang4, Stuart J Johnstone5.   

Abstract

The current gold standard for the diagnosis of AD/HD is based on subjective reports from teachers, parents, and clinicians. These measures can be problematic as they are open to rater biases and also fail to account for the developmental nature of symptoms. The current study examined the diagnostic accuracy of two objective measures, a computer-based Continuous Performance Task and actigraphy (e.g. motion tracking device) in differentiating children with AD/HD (N=70) from healthy controls (N=70). It was predicted that task-unrelated movement (measured via actigraphy) during a CPT and CPT performance would have high classification accuracy in differentiating children with AD/HD from healthy controls, and that the inclusion of age would increase this accuracy. Results indicated that total energy expenditure from the task-unrelated wrist and ankle movement during the CPT was higher in children with AD/HD than controls, and that CPT performance was poorer in AD/HD than controls. Discriminant function analyses revealed that the CPT Full-Scale Response Control Quotient and wrist and ankle energy expenditure provided optimal classification accuracy - correctly classifying 86% of cases, with sensitivity of 81.4% and specificity of 91.4%. The prediction that classification accuracy would increase with the inclusion of age was not supported by the data. When taken in conjunction with other clinical assessments, these findings suggest that actigraphy during a CPT and CPT performance may increase the probability of a correct AD/HD diagnosis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AD/HD; Actigraphy; CPT; Diagnosis; Objective

Mesh:

Year:  2016        PMID: 27497372     DOI: 10.1016/j.ridd.2016.07.013

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  5 in total

Review 1.  Toward Precision Medicine in ADHD.

Authors:  Jan Buitelaar; Sven Bölte; Daniel Brandeis; Arthur Caye; Nina Christmann; Samuele Cortese; David Coghill; Stephen V Faraone; Barbara Franke; Markus Gleitz; Corina U Greven; Sandra Kooij; Douglas Teixeira Leffa; Nanda Rommelse; Jeffrey H Newcorn; Guilherme V Polanczyk; Luis Augusto Rohde; Emily Simonoff; Mark Stein; Benedetto Vitiello; Yanki Yazgan; Michael Roesler; Manfred Doepfner; Tobias Banaschewski
Journal:  Front Behav Neurosci       Date:  2022-07-06       Impact factor: 3.617

2.  The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial.

Authors:  Chris Hollis; Charlotte L Hall; Boliang Guo; Marilyn James; Janet Boadu; Madeleine J Groom; Nikki Brown; Catherine Kaylor-Hughes; Maria Moldavsky; Althea Z Valentine; Gemma M Walker; David Daley; Kapil Sayal; Richard Morriss
Journal:  J Child Psychol Psychiatry       Date:  2018-04-26       Impact factor: 8.982

3.  Predicting ADHD symptoms and diagnosis at age 14 from objective activity levels at age 7 in a large UK cohort.

Authors:  Valerie Brandt; Praveetha Patalay; Julia Kerner Auch Koerner
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-06-06       Impact factor: 4.785

4.  Comparative efficacy of targeted structural patterns of electroencephalography neurofeedback in children with inattentive or combined attention deficit hyperactivity disorder.

Authors:  Feng-Hua Wang; Li-Yan Sun; Xiao-Mei Cui; He-Dan Zhao; Ling-Fei Yang; Zheng Wang; Tong-Kun Shi
Journal:  Brain Behav       Date:  2022-04-24       Impact factor: 3.405

5.  Microsoft Kinect-based Continuous Performance Test: An Objective Attention Deficit Hyperactivity Disorder Assessment.

Authors:  David Delgado-Gomez; Inmaculada Peñuelas-Calvo; Antonio Eduardo Masó-Besga; Silvia Vallejo-Oñate; Itziar Baltasar Tello; Elsa Arrua Duarte; María Constanza Vera Varela; Juan Carballo; Enrique Baca-García
Journal:  J Med Internet Res       Date:  2017-03-20       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.